{"id":"W2900357627","doi":"10.1002/ajh.25342","title":"Treatment‐free remission with first‐ and second‐generation tyrosine kinase inhibitors","year":2018,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":147,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Bristol-Myers Squibb","keywords":"Nilotinib; Dasatinib; Discontinuation; Medicine; Imatinib; Bosutinib; Clinical trial; Tyrosine-kinase inhibitor; Tyrosine kinase; Myeloid leukemia; Oncology; Intensive care medicine; Imatinib mesylate; Internal medicine; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004708661,0.0006043735,0.001225527,0.001939239,0.0002674096,0.0007303436,0.0006704266,0.0006911587,0.004572104],"category_scores_gemma":[0.0008951131,0.0001866704,0.0006730811,0.001699021,0.0002888101,0.0009040858,0.0004861815,0.001293908,0.001656069],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004428181,"about_ca_system_score_gemma":0.0009667994,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008337513,"about_ca_topic_score_gemma":0.001778712,"domain_scores_codex":[0.9997357,0.00004796225,0.00004937499,0.00003935913,0.0001093431,0.00001839547],"domain_scores_gemma":[0.9997328,0.0001278331,0.00005433679,0.000009055501,0.00005830654,0.00001769648],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007249404,0.00005278925,0.0001523344,0.03402414,0.0001291182,0.0001184291,0.00005272474,0.0002080074,0.00100076,0.002796602,0.03385495,0.9275377],"study_design_scores_gemma":[0.00002576113,0.00007688688,0.0008722211,0.008165524,0.0001695372,0.001315852,0.00004479279,0.00004885587,0.0003106518,0.001131321,0.9878265,0.00001202775],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001083338,0.9983736,0.00005830796,0.0001676487,0.0001261506,0.000006256387,0.00002732344,0.000004881605,0.00112739],"genre_scores_gemma":[0.0006763697,0.9985393,0.0001059638,0.000144584,0.00007929466,0.000007919879,0.00004084379,0.00000119967,0.0004043889],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004572104,"threshold_uncertainty_score":0.01529515,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02730329211227252,"score_gpt":0.3110332930561482,"score_spread":0.2837300009438757,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}